Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
B-Lymphocytes | 45 | 2018 | 724 | 3.590 |
Why?
|
Antibodies, Antinuclear | 27 | 2014 | 83 | 3.530 |
Why?
|
Immunoglobulin Variable Region | 42 | 2018 | 109 | 2.990 |
Why?
|
Immunoglobulin kappa-Chains | 33 | 2011 | 96 | 2.070 |
Why?
|
Immunoglobulin Light Chains | 28 | 2014 | 86 | 1.970 |
Why?
|
Immunoglobulin Heavy Chains | 40 | 2014 | 131 | 1.950 |
Why?
|
Receptors, Antigen, B-Cell | 13 | 2012 | 113 | 1.920 |
Why?
|
Genes, Immunoglobulin | 19 | 2012 | 111 | 1.850 |
Why?
|
Autoantibodies | 16 | 2018 | 267 | 1.700 |
Why?
|
Autoimmunity | 9 | 2011 | 160 | 1.680 |
Why?
|
DNA | 28 | 2014 | 1294 | 1.460 |
Why?
|
Immune Tolerance | 14 | 2022 | 337 | 1.280 |
Why?
|
Lupus Erythematosus, Systemic | 9 | 2018 | 206 | 1.280 |
Why?
|
Gene Rearrangement, B-Lymphocyte, Light Chain | 10 | 2008 | 24 | 1.220 |
Why?
|
Gene Rearrangement, B-Lymphocyte | 11 | 2011 | 37 | 1.180 |
Why?
|
Mice, Transgenic | 30 | 2014 | 1540 | 1.020 |
Why?
|
Hybridomas | 29 | 2013 | 74 | 0.980 |
Why?
|
Mice | 99 | 2016 | 11352 | 0.940 |
Why?
|
Base Sequence | 41 | 2013 | 2330 | 0.910 |
Why?
|
Complementarity Determining Regions | 4 | 2014 | 24 | 0.850 |
Why?
|
Molecular Sequence Data | 36 | 2014 | 3030 | 0.840 |
Why?
|
Immunoglobulin Class Switching | 3 | 2018 | 37 | 0.800 |
Why?
|
Hemagglutinins, Viral | 6 | 2008 | 38 | 0.750 |
Why?
|
Autoantigens | 10 | 2018 | 127 | 0.750 |
Why?
|
Amino Acid Sequence | 40 | 2014 | 2062 | 0.730 |
Why?
|
B-Lymphocyte Subsets | 4 | 2011 | 40 | 0.710 |
Why?
|
Animals | 107 | 2016 | 26582 | 0.700 |
Why?
|
Mice, Inbred BALB C | 30 | 2011 | 1047 | 0.690 |
Why?
|
Binding Sites, Antibody | 18 | 2006 | 49 | 0.600 |
Why?
|
Epitopes | 11 | 2018 | 255 | 0.600 |
Why?
|
Antibody Specificity | 17 | 2014 | 129 | 0.590 |
Why?
|
Immunoglobulin M | 10 | 2013 | 154 | 0.560 |
Why?
|
Antibodies, Viral | 5 | 2008 | 293 | 0.560 |
Why?
|
Rheumatoid Factor | 10 | 1997 | 24 | 0.550 |
Why?
|
Antibodies, Monoclonal | 13 | 2008 | 1376 | 0.500 |
Why?
|
Gene Rearrangement, B-Lymphocyte, Heavy Chain | 4 | 2003 | 20 | 0.500 |
Why?
|
Models, Immunological | 7 | 2005 | 80 | 0.480 |
Why?
|
Immunoglobulin G | 11 | 2003 | 456 | 0.450 |
Why?
|
Mutation | 17 | 2015 | 3967 | 0.450 |
Why?
|
Autoimmune Diseases | 9 | 2004 | 241 | 0.430 |
Why?
|
Somatic Hypermutation, Immunoglobulin | 2 | 2011 | 32 | 0.420 |
Why?
|
Antibody Formation | 4 | 2007 | 171 | 0.410 |
Why?
|
DNA, Single-Stranded | 5 | 1999 | 92 | 0.400 |
Why?
|
RNA Editing | 3 | 2006 | 34 | 0.400 |
Why?
|
Immunoglobulin lambda-Chains | 9 | 2004 | 42 | 0.390 |
Why?
|
Antibody Diversity | 11 | 2007 | 25 | 0.370 |
Why?
|
Recombination, Genetic | 17 | 2002 | 439 | 0.330 |
Why?
|
Self Tolerance | 5 | 2014 | 24 | 0.330 |
Why?
|
Spleen | 7 | 2006 | 430 | 0.330 |
Why?
|
Precursor Cells, B-Lymphoid | 2 | 2022 | 27 | 0.310 |
Why?
|
Mice, Inbred MRL lpr | 6 | 2011 | 36 | 0.300 |
Why?
|
Influenza A Virus, H1N1 Subtype | 1 | 2008 | 102 | 0.300 |
Why?
|
Phosphatidylserines | 3 | 2008 | 20 | 0.300 |
Why?
|
Immunoglobulin Idiotypes | 4 | 1992 | 12 | 0.290 |
Why?
|
Graft vs Host Reaction | 1 | 2006 | 15 | 0.290 |
Why?
|
Apoptosis | 5 | 2022 | 1683 | 0.280 |
Why?
|
Antibodies, Antiphospholipid | 2 | 2003 | 10 | 0.280 |
Why?
|
Immunologic Memory | 5 | 2018 | 152 | 0.280 |
Why?
|
Sequence Homology, Amino Acid | 6 | 2014 | 416 | 0.270 |
Why?
|
Genome, Viral | 1 | 2005 | 74 | 0.260 |
Why?
|
Alleles | 13 | 2006 | 1128 | 0.260 |
Why?
|
Bone Marrow | 2 | 2023 | 435 | 0.260 |
Why?
|
Epitopes, T-Lymphocyte | 1 | 2005 | 89 | 0.250 |
Why?
|
Data Collection | 1 | 2006 | 372 | 0.250 |
Why?
|
Microscopy, Fluorescence | 1 | 2006 | 425 | 0.250 |
Why?
|
Myeloma Proteins | 20 | 1981 | 32 | 0.250 |
Why?
|
Gene Rearrangement | 4 | 2006 | 170 | 0.250 |
Why?
|
Immunoglobulin Joining Region | 3 | 2000 | 13 | 0.240 |
Why?
|
Influenza A virus | 3 | 1991 | 169 | 0.240 |
Why?
|
Cell Differentiation | 6 | 2007 | 1458 | 0.240 |
Why?
|
Genes | 15 | 1986 | 305 | 0.230 |
Why?
|
Flow Cytometry | 7 | 2012 | 679 | 0.230 |
Why?
|
Phenotype | 2 | 2012 | 2378 | 0.230 |
Why?
|
Models, Molecular | 9 | 2013 | 1286 | 0.230 |
Why?
|
Hematology | 1 | 2023 | 29 | 0.220 |
Why?
|
Glycosaminoglycans | 2 | 2013 | 47 | 0.220 |
Why?
|
Blotting, Southern | 8 | 1994 | 129 | 0.210 |
Why?
|
Isoantigens | 1 | 2002 | 66 | 0.210 |
Why?
|
Golgi Apparatus | 2 | 2013 | 117 | 0.200 |
Why?
|
Sequence Alignment | 4 | 2006 | 351 | 0.200 |
Why?
|
snRNP Core Proteins | 2 | 2018 | 9 | 0.200 |
Why?
|
Mutagenesis, Site-Directed | 6 | 2004 | 279 | 0.190 |
Why?
|
Antibodies, Anti-Idiotypic | 3 | 1990 | 44 | 0.190 |
Why?
|
Transgenes | 5 | 2007 | 180 | 0.190 |
Why?
|
Genome, Human | 1 | 2005 | 756 | 0.190 |
Why?
|
Antibody Affinity | 3 | 2014 | 38 | 0.180 |
Why?
|
Mice, Inbred Strains | 11 | 2002 | 307 | 0.180 |
Why?
|
Plasmacytoma | 10 | 1987 | 34 | 0.180 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2006 | 1204 | 0.180 |
Why?
|
Genetic Linkage | 6 | 1989 | 623 | 0.170 |
Why?
|
Polymerase Chain Reaction | 5 | 2016 | 927 | 0.170 |
Why?
|
Immunoglobulin Fragments | 7 | 2009 | 23 | 0.170 |
Why?
|
DNA-Binding Proteins | 3 | 2002 | 1208 | 0.170 |
Why?
|
Humans | 30 | 2023 | 86617 | 0.170 |
Why?
|
Cell Line | 7 | 2011 | 2468 | 0.160 |
Why?
|
DNA Repair Enzymes | 1 | 1998 | 52 | 0.160 |
Why?
|
Mice, Mutant Strains | 8 | 2002 | 229 | 0.150 |
Why?
|
Disease Susceptibility | 1 | 2018 | 193 | 0.150 |
Why?
|
Adenosine Triphosphatases | 1 | 1998 | 153 | 0.150 |
Why?
|
Genetic Markers | 1 | 2018 | 476 | 0.150 |
Why?
|
Central Tolerance | 1 | 2016 | 8 | 0.150 |
Why?
|
Models, Genetic | 5 | 2005 | 926 | 0.140 |
Why?
|
Protein Conformation | 4 | 2013 | 881 | 0.140 |
Why?
|
Fluorescent Antibody Technique | 4 | 2013 | 316 | 0.140 |
Why?
|
Pericytes | 1 | 2016 | 12 | 0.140 |
Why?
|
Gene Expression Regulation | 7 | 2016 | 1920 | 0.140 |
Why?
|
Mice, Inbred C57BL | 10 | 2007 | 3092 | 0.140 |
Why?
|
Lymphoma | 2 | 1989 | 262 | 0.140 |
Why?
|
Antigen-Presenting Cells | 1 | 2016 | 139 | 0.140 |
Why?
|
Coculture Techniques | 1 | 2016 | 164 | 0.140 |
Why?
|
Membrane Proteins | 1 | 2022 | 1196 | 0.140 |
Why?
|
DNA Repair | 1 | 1998 | 356 | 0.140 |
Why?
|
RNA-Binding Protein FUS | 1 | 2015 | 11 | 0.140 |
Why?
|
T-Lymphocytes | 2 | 2016 | 1195 | 0.130 |
Why?
|
Cell Communication | 1 | 2016 | 194 | 0.130 |
Why?
|
Ribonucleoproteins, Small Nuclear | 1 | 1994 | 20 | 0.130 |
Why?
|
Paraproteinemias | 1 | 2014 | 13 | 0.130 |
Why?
|
Sumoylation | 1 | 2014 | 18 | 0.130 |
Why?
|
Microscopy | 1 | 2015 | 87 | 0.130 |
Why?
|
HSP90 Heat-Shock Proteins | 1 | 2014 | 46 | 0.130 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 5 | 2012 | 376 | 0.120 |
Why?
|
Clonal Deletion | 1 | 1994 | 23 | 0.120 |
Why?
|
Proteins | 2 | 1998 | 777 | 0.120 |
Why?
|
Amyotrophic Lateral Sclerosis | 1 | 2015 | 182 | 0.120 |
Why?
|
Wound Healing | 1 | 2016 | 344 | 0.120 |
Why?
|
DNA Primers | 3 | 2004 | 543 | 0.120 |
Why?
|
Endothelial Cells | 1 | 2016 | 428 | 0.110 |
Why?
|
Dextrans | 6 | 1980 | 77 | 0.110 |
Why?
|
Receptors, Immunologic | 2 | 2007 | 135 | 0.110 |
Why?
|
Bone Marrow Cells | 4 | 2023 | 253 | 0.110 |
Why?
|
Gene Expression | 3 | 2012 | 1284 | 0.110 |
Why?
|
Receptors, Cell Surface | 1 | 2014 | 286 | 0.110 |
Why?
|
HIV Antibodies | 1 | 2011 | 25 | 0.100 |
Why?
|
Immunization, Passive | 1 | 2011 | 71 | 0.100 |
Why?
|
Immune Complex Diseases | 1 | 2011 | 19 | 0.100 |
Why?
|
Lymphocyte Activation | 6 | 2016 | 728 | 0.100 |
Why?
|
Restriction Mapping | 4 | 1993 | 157 | 0.100 |
Why?
|
Mice, Knockout | 2 | 2011 | 1924 | 0.100 |
Why?
|
Mice, Inbred A | 1 | 2011 | 23 | 0.100 |
Why?
|
Cross Reactions | 5 | 2004 | 106 | 0.100 |
Why?
|
Antigen-Antibody Complex | 1 | 2011 | 87 | 0.100 |
Why?
|
Case-Control Studies | 2 | 2014 | 1804 | 0.100 |
Why?
|
Lymphopenia | 1 | 2011 | 28 | 0.100 |
Why?
|
Imaging, Three-Dimensional | 1 | 2015 | 579 | 0.100 |
Why?
|
Antibodies, Neutralizing | 1 | 2011 | 112 | 0.100 |
Why?
|
Aging | 2 | 2015 | 691 | 0.100 |
Why?
|
Models, Biological | 2 | 2016 | 1749 | 0.100 |
Why?
|
Software | 1 | 2015 | 654 | 0.100 |
Why?
|
Genes, Switch | 1 | 1990 | 8 | 0.100 |
Why?
|
Translocation, Genetic | 3 | 1987 | 265 | 0.100 |
Why?
|
Orthomyxoviridae | 1 | 1990 | 37 | 0.090 |
Why?
|
Genes, Regulator | 1 | 1990 | 65 | 0.090 |
Why?
|
Cloning, Molecular | 5 | 1994 | 646 | 0.090 |
Why?
|
Immunoglobulin Isotypes | 3 | 2002 | 32 | 0.090 |
Why?
|
Graft vs Host Disease | 2 | 2003 | 365 | 0.090 |
Why?
|
Genetic Loci | 1 | 2011 | 250 | 0.090 |
Why?
|
Immunoglobulins | 5 | 1982 | 148 | 0.090 |
Why?
|
Indoles | 2 | 2012 | 318 | 0.080 |
Why?
|
Multigene Family | 1 | 1989 | 202 | 0.080 |
Why?
|
Antibodies | 4 | 1980 | 350 | 0.070 |
Why?
|
Immunoglobulin Allotypes | 3 | 2003 | 5 | 0.070 |
Why?
|
Female | 12 | 2018 | 44509 | 0.070 |
Why?
|
Immune System | 1 | 2007 | 93 | 0.070 |
Why?
|
Clone Cells | 4 | 1998 | 213 | 0.070 |
Why?
|
Immunoglobulin Subunits | 1 | 2006 | 2 | 0.070 |
Why?
|
Cell Membrane | 1 | 2009 | 666 | 0.070 |
Why?
|
Lymphocyte Count | 1 | 2006 | 94 | 0.070 |
Why?
|
Histocompatibility Antigens | 1 | 2005 | 35 | 0.070 |
Why?
|
United States | 1 | 2018 | 6665 | 0.070 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 1 | 2005 | 100 | 0.070 |
Why?
|
Chronic Disease | 2 | 2006 | 971 | 0.070 |
Why?
|
Antigens, Viral | 1 | 2005 | 143 | 0.060 |
Why?
|
Mice, Inbred NZB | 7 | 1982 | 13 | 0.060 |
Why?
|
Lipopolysaccharides | 4 | 2006 | 286 | 0.060 |
Why?
|
Transcription, Genetic | 4 | 1991 | 1135 | 0.060 |
Why?
|
Immunoglobulin D | 1 | 2004 | 5 | 0.060 |
Why?
|
Immunomagnetic Separation | 1 | 2004 | 8 | 0.060 |
Why?
|
Quantitative Trait Loci | 1 | 2008 | 576 | 0.060 |
Why?
|
Arginine | 2 | 1995 | 136 | 0.060 |
Why?
|
Receptors, Interleukin-2 | 1 | 2004 | 66 | 0.060 |
Why?
|
Monte Carlo Method | 2 | 2009 | 185 | 0.060 |
Why?
|
Species Specificity | 6 | 1990 | 678 | 0.060 |
Why?
|
Animals, Congenic | 1 | 2003 | 1 | 0.060 |
Why?
|
Peptides | 2 | 2005 | 639 | 0.060 |
Why?
|
HIV Infections | 1 | 2011 | 772 | 0.060 |
Why?
|
Static Electricity | 1 | 2003 | 89 | 0.060 |
Why?
|
Bone Marrow Examination | 1 | 2023 | 48 | 0.060 |
Why?
|
Forkhead Box Protein O1 | 1 | 2022 | 23 | 0.060 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2022 | 36 | 0.050 |
Why?
|
Visual Perception | 1 | 2006 | 319 | 0.050 |
Why?
|
RNA, Messenger | 5 | 1991 | 1981 | 0.050 |
Why?
|
Workflow | 1 | 2023 | 77 | 0.050 |
Why?
|
Crosses, Genetic | 6 | 2012 | 171 | 0.050 |
Why?
|
Isoelectric Point | 1 | 2001 | 16 | 0.050 |
Why?
|
Algorithms | 3 | 2009 | 1830 | 0.050 |
Why?
|
Lysosomes | 1 | 2022 | 104 | 0.050 |
Why?
|
Computer Simulation | 3 | 2009 | 1078 | 0.050 |
Why?
|
PTEN Phosphohydrolase | 1 | 2022 | 128 | 0.050 |
Why?
|
Microscopy, Confocal | 2 | 2013 | 268 | 0.050 |
Why?
|
Codon | 1 | 2001 | 124 | 0.050 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2022 | 165 | 0.050 |
Why?
|
Chromatin | 1 | 2004 | 380 | 0.050 |
Why?
|
Transfection | 3 | 1994 | 896 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2022 | 322 | 0.050 |
Why?
|
Antigens, CD | 1 | 2002 | 458 | 0.050 |
Why?
|
Polymorphism, Genetic | 1 | 1985 | 819 | 0.050 |
Why?
|
Immunophenotyping | 3 | 2007 | 211 | 0.050 |
Why?
|
Amino Acid Substitution | 1 | 2001 | 339 | 0.050 |
Why?
|
Glycoproteins | 1 | 2001 | 234 | 0.050 |
Why?
|
Mutation, Missense | 1 | 2001 | 276 | 0.050 |
Why?
|
Cell Line, Tumor | 1 | 2006 | 2426 | 0.050 |
Why?
|
Haplotypes | 1 | 2002 | 642 | 0.050 |
Why?
|
Cardiolipins | 2 | 1991 | 17 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 2 | 2007 | 2270 | 0.040 |
Why?
|
Immunoglobulin Switch Region | 2 | 1990 | 10 | 0.040 |
Why?
|
Reproducibility of Results | 1 | 2006 | 2705 | 0.040 |
Why?
|
Models, Statistical | 1 | 2002 | 574 | 0.040 |
Why?
|
Protein Structure, Tertiary | 2 | 2015 | 736 | 0.040 |
Why?
|
Mismatch Repair Endonuclease PMS2 | 1 | 1998 | 23 | 0.040 |
Why?
|
Sequence Homology, Nucleic Acid | 2 | 1989 | 173 | 0.040 |
Why?
|
Liver | 3 | 1990 | 1230 | 0.040 |
Why?
|
Cell Nucleus | 2 | 2015 | 579 | 0.040 |
Why?
|
Immunoglobulin J-Chains | 2 | 1987 | 12 | 0.040 |
Why?
|
Thymocytes | 1 | 2016 | 30 | 0.040 |
Why?
|
Clonal Anergy | 1 | 1996 | 30 | 0.040 |
Why?
|
Granulation Tissue | 1 | 2016 | 15 | 0.040 |
Why?
|
Dermis | 1 | 2016 | 27 | 0.040 |
Why?
|
Sequence Deletion | 1 | 1997 | 205 | 0.040 |
Why?
|
Chromosome Mapping | 6 | 1985 | 1074 | 0.040 |
Why?
|
Neoplasms, Experimental | 6 | 1983 | 269 | 0.030 |
Why?
|
Deoxyribonucleoproteins | 1 | 1995 | 2 | 0.030 |
Why?
|
Microvessels | 1 | 2016 | 70 | 0.030 |
Why?
|
Cell Count | 1 | 2016 | 195 | 0.030 |
Why?
|
Antigens, Ly | 2 | 1986 | 37 | 0.030 |
Why?
|
Protein Aggregates | 1 | 2015 | 20 | 0.030 |
Why?
|
Prealbumin | 1 | 1975 | 34 | 0.030 |
Why?
|
Prions | 1 | 2015 | 54 | 0.030 |
Why?
|
Jurkat Cells | 2 | 2008 | 77 | 0.030 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 1997 | 372 | 0.030 |
Why?
|
SUMO-1 Protein | 1 | 2014 | 16 | 0.030 |
Why?
|
Computer Graphics | 1 | 2015 | 100 | 0.030 |
Why?
|
Immunologic Techniques | 1 | 1994 | 27 | 0.030 |
Why?
|
Serum Albumin | 1 | 1975 | 130 | 0.030 |
Why?
|
Real-Time Polymerase Chain Reaction | 1 | 2016 | 273 | 0.030 |
Why?
|
Oligosaccharides | 2 | 1974 | 24 | 0.030 |
Why?
|
Genes, Dominant | 1 | 2014 | 117 | 0.030 |
Why?
|
Point Mutation | 1 | 1995 | 246 | 0.030 |
Why?
|
Information Storage and Retrieval | 1 | 2015 | 120 | 0.030 |
Why?
|
Cytoplasm | 1 | 2015 | 281 | 0.030 |
Why?
|
Mice, Inbred C3H | 3 | 1987 | 370 | 0.030 |
Why?
|
Haptens | 4 | 1979 | 9 | 0.030 |
Why?
|
Immunoglobulin Constant Regions | 2 | 1985 | 21 | 0.030 |
Why?
|
Genotype | 3 | 2006 | 1851 | 0.030 |
Why?
|
Heterozygote | 1 | 2014 | 365 | 0.030 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2016 | 425 | 0.030 |
Why?
|
Recombinant Fusion Proteins | 1 | 1995 | 557 | 0.030 |
Why?
|
Electrochemistry | 1 | 1993 | 61 | 0.030 |
Why?
|
Luminescent Measurements | 1 | 2013 | 57 | 0.030 |
Why?
|
Conserved Sequence | 1 | 2014 | 210 | 0.030 |
Why?
|
Structure-Activity Relationship | 2 | 1993 | 408 | 0.030 |
Why?
|
Immunoassay | 1 | 2013 | 92 | 0.030 |
Why?
|
X-Ray Diffraction | 1 | 2013 | 124 | 0.030 |
Why?
|
Pedigree | 1 | 2014 | 966 | 0.030 |
Why?
|
Immunogenetics | 1 | 1972 | 9 | 0.030 |
Why?
|
Clodronic Acid | 1 | 2012 | 9 | 0.030 |
Why?
|
Ligands | 2 | 2009 | 433 | 0.030 |
Why?
|
Liposomes | 1 | 2012 | 91 | 0.030 |
Why?
|
CD40 Ligand | 1 | 2012 | 69 | 0.030 |
Why?
|
Hemocyanins | 1 | 1991 | 7 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-bcr | 1 | 2011 | 7 | 0.030 |
Why?
|
Databases, Factual | 1 | 2015 | 812 | 0.030 |
Why?
|
Blotting, Northern | 1 | 1991 | 256 | 0.030 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2011 | 134 | 0.030 |
Why?
|
Rabbits | 2 | 1984 | 636 | 0.020 |
Why?
|
Viral Load | 1 | 2011 | 148 | 0.020 |
Why?
|
Multiple Myeloma | 2 | 1979 | 307 | 0.020 |
Why?
|
Binding, Competitive | 3 | 1984 | 145 | 0.020 |
Why?
|
Oligonucleotides | 1 | 1991 | 92 | 0.020 |
Why?
|
Immunoblotting | 1 | 2011 | 268 | 0.020 |
Why?
|
Kinetics | 2 | 1994 | 1513 | 0.020 |
Why?
|
Oligonucleotide Probes | 1 | 1990 | 39 | 0.020 |
Why?
|
Mice, Inbred AKR | 3 | 1980 | 10 | 0.020 |
Why?
|
Blotting, Western | 1 | 2011 | 782 | 0.020 |
Why?
|
Radioimmunoassay | 2 | 1984 | 155 | 0.020 |
Why?
|
Embryonic and Fetal Development | 1 | 1989 | 72 | 0.020 |
Why?
|
src-Family Kinases | 1 | 2009 | 74 | 0.020 |
Why?
|
Immunoglobulin A | 4 | 1979 | 80 | 0.020 |
Why?
|
Cell Line, Transformed | 1 | 1989 | 154 | 0.020 |
Why?
|
In Vitro Techniques | 1 | 1991 | 989 | 0.020 |
Why?
|
Models, Theoretical | 1 | 2011 | 482 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 1991 | 1014 | 0.020 |
Why?
|
Bone Marrow Transplantation | 2 | 2002 | 286 | 0.020 |
Why?
|
Lymphocyte Subsets | 1 | 2008 | 64 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2012 | 1753 | 0.020 |
Why?
|
Genes, Immunoglobulin Heavy Chain | 1 | 2007 | 9 | 0.020 |
Why?
|
Antigens, Nuclear | 1 | 2007 | 25 | 0.020 |
Why?
|
Computers | 1 | 2007 | 112 | 0.020 |
Why?
|
Immunization, Secondary | 1 | 1987 | 30 | 0.020 |
Why?
|
Signal Transduction | 2 | 2009 | 3241 | 0.020 |
Why?
|
Stem Cells | 1 | 1989 | 351 | 0.020 |
Why?
|
Phosphorylation | 1 | 2009 | 1106 | 0.020 |
Why?
|
Male | 5 | 2014 | 40958 | 0.020 |
Why?
|
Leukocyte Count | 1 | 1986 | 220 | 0.020 |
Why?
|
Gene Rearrangement, beta-Chain T-Cell Antigen Receptor | 1 | 2005 | 17 | 0.020 |
Why?
|
Gene Rearrangement, alpha-Chain T-Cell Antigen Receptor | 1 | 2005 | 9 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 1987 | 1041 | 0.020 |
Why?
|
Stochastic Processes | 1 | 2005 | 74 | 0.020 |
Why?
|
Middle Aged | 2 | 2014 | 25017 | 0.020 |
Why?
|
Hemagglutinin Glycoproteins, Influenza Virus | 1 | 1985 | 70 | 0.020 |
Why?
|
DNA Restriction Enzymes | 1 | 1985 | 98 | 0.020 |
Why?
|
Adult | 2 | 2014 | 25640 | 0.020 |
Why?
|
Genetic Code | 3 | 1974 | 25 | 0.020 |
Why?
|
Time Factors | 2 | 2007 | 5209 | 0.020 |
Why?
|
Antigens | 2 | 2003 | 228 | 0.020 |
Why?
|
Binding Sites | 3 | 1978 | 1098 | 0.020 |
Why?
|
Risk Factors | 1 | 2014 | 5417 | 0.020 |
Why?
|
Cell Division | 1 | 2005 | 696 | 0.020 |
Why?
|
Hybrid Cells | 2 | 1981 | 72 | 0.010 |
Why?
|
Genetic Variation | 1 | 1970 | 1351 | 0.010 |
Why?
|
Chromosome Deletion | 2 | 1981 | 229 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2006 | 853 | 0.010 |
Why?
|
beta 2-Glycoprotein I | 1 | 2001 | 5 | 0.010 |
Why?
|
Young Adult | 1 | 2014 | 5974 | 0.010 |
Why?
|
Leukemia, Experimental | 1 | 1981 | 15 | 0.010 |
Why?
|
Ascitic Fluid | 1 | 1981 | 37 | 0.010 |
Why?
|
Nucleic Acid Precursors | 1 | 1980 | 3 | 0.010 |
Why?
|
DNA, Recombinant | 1 | 1980 | 67 | 0.010 |
Why?
|
RNA, Neoplasm | 1 | 1980 | 87 | 0.010 |
Why?
|
H-2 Antigens | 1 | 1980 | 58 | 0.010 |
Why?
|
Rats | 1 | 1985 | 3990 | 0.010 |
Why?
|
Cytochrome c Group | 1 | 1997 | 82 | 0.010 |
Why?
|
Entropy | 1 | 1997 | 38 | 0.010 |
Why?
|
Aged | 1 | 2014 | 18402 | 0.010 |
Why?
|
Dimerization | 1 | 1997 | 143 | 0.010 |
Why?
|
Erythrocytes | 2 | 1982 | 255 | 0.010 |
Why?
|
Immunochemistry | 2 | 1974 | 16 | 0.010 |
Why?
|
Biological Evolution | 1 | 1985 | 919 | 0.010 |
Why?
|
Radiation Chimera | 1 | 1996 | 23 | 0.010 |
Why?
|
Adoptive Transfer | 1 | 1996 | 168 | 0.010 |
Why?
|
Arthritis, Rheumatoid | 1 | 1997 | 166 | 0.010 |
Why?
|
Isoantibodies | 1 | 1977 | 114 | 0.010 |
Why?
|
Crossing Over, Genetic | 1 | 1975 | 33 | 0.010 |
Why?
|
Mice, Inbred DBA | 1 | 1975 | 148 | 0.010 |
Why?
|
Autoanalysis | 1 | 1973 | 6 | 0.010 |
Why?
|
Thermolysin | 1 | 1973 | 9 | 0.010 |
Why?
|
Chromatography | 1 | 1973 | 28 | 0.010 |
Why?
|
Chymotrypsin | 1 | 1973 | 28 | 0.010 |
Why?
|
Electrophoresis | 1 | 1973 | 55 | 0.010 |
Why?
|
Trypsin | 1 | 1973 | 95 | 0.010 |
Why?
|
DNA, Complementary | 1 | 1994 | 393 | 0.010 |
Why?
|
Iodine Radioisotopes | 1 | 1974 | 134 | 0.010 |
Why?
|
Hydrolysis | 1 | 1973 | 141 | 0.010 |
Why?
|
Iodine Isotopes | 1 | 1973 | 18 | 0.010 |
Why?
|
Antigen-Antibody Reactions | 1 | 1973 | 23 | 0.010 |
Why?
|
Disaccharides | 1 | 1973 | 23 | 0.010 |
Why?
|
Maltose | 1 | 1973 | 33 | 0.010 |
Why?
|
Immune Sera | 1 | 1972 | 52 | 0.010 |
Why?
|
Sheep | 1 | 1972 | 239 | 0.010 |
Why?
|
Cryoglobulins | 1 | 1992 | 4 | 0.010 |
Why?
|
Immunization | 1 | 1972 | 158 | 0.010 |
Why?
|
Polysaccharides | 1 | 1972 | 89 | 0.010 |
Why?
|
Glomerulonephritis | 1 | 1992 | 75 | 0.010 |
Why?
|
Syndrome | 1 | 1992 | 446 | 0.010 |
Why?
|
Molecular Biology | 1 | 1970 | 89 | 0.010 |
Why?
|
Skin Diseases | 1 | 1992 | 166 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 1996 | 2232 | 0.010 |
Why?
|
Nucleic Acid Hybridization | 2 | 1978 | 245 | 0.010 |
Why?
|
Selection, Genetic | 1 | 1970 | 502 | 0.000 |
Why?
|
Animals, Wild | 1 | 1982 | 40 | 0.000 |
Why?
|
Protein Binding | 2 | 1978 | 1456 | 0.000 |
Why?
|
Gene Amplification | 1 | 1982 | 131 | 0.000 |
Why?
|
Antilymphocyte Serum | 1 | 1982 | 71 | 0.000 |
Why?
|
Coliphages | 1 | 1979 | 59 | 0.000 |
Why?
|
Extracellular Space | 1 | 1979 | 90 | 0.000 |
Why?
|
Immunoglobulin alpha-Chains | 1 | 1978 | 4 | 0.000 |
Why?
|
Immunoglobulin gamma-Chains | 1 | 1978 | 14 | 0.000 |
Why?
|
Immunoglobulin mu-Chains | 1 | 1978 | 18 | 0.000 |
Why?
|
Phosphorylcholine | 1 | 1978 | 28 | 0.000 |
Why?
|
Nitrobenzenes | 1 | 1975 | 11 | 0.000 |
Why?
|
Inulin | 1 | 1972 | 17 | 0.000 |
Why?
|
Precipitin Tests | 1 | 1972 | 108 | 0.000 |
Why?
|
Fructose | 1 | 1972 | 35 | 0.000 |
Why?
|
Glucose | 1 | 1972 | 638 | 0.000 |
Why?
|